Insider Transactions in Q4 2020 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2020
|
Kevin E Lofton Director |
SELL
Bona fide gift
|
Direct |
21,720
-28.71%
|
-
|
|
Nov 10
2020
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
611
-4.13%
|
$36,660
$60.62 P/Share
|
|
Nov 10
2020
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,430
+4.71%
|
-
|
|
Nov 10
2020
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,416
-47.36%
|
$144,960
$60.62 P/Share
|
|
Nov 10
2020
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,101
+50.0%
|
-
|
|
Nov 10
2020
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,399
-7.91%
|
$83,940
$60.62 P/Share
|
|
Nov 10
2020
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,046
+8.23%
|
-
|
|
Nov 03
2020
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,282
-40.69%
|
$712,356
$58.83 P/Share
|
|
Nov 03
2020
|
Johanna Mercier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,270
+46.53%
|
-
|
|
Oct 01
2020
|
Richard James Whitley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,434
+4.4%
|
-
|